News
-
-
PRESS RELEASE
DEFENCE INVESTIGATES THE APPLICATION OF THE ACCUM® HYDROGEL TECHNOLOGY TO DELIVER GLP-1 IN ORDER TO INCREASE THE TREATMENT EFFICACY OF DIABETES AND WEIGHT LOSS
Defence Therapeutics Inc. explores using Accum® Hydrogel technology to enhance GLP-1 treatment for diabetes & weight loss. GLP-1 drugs aim to tackle obesity & comorbidities, amid growing global health challenges -
PRESS RELEASE
CyberGuard Advantage Expands Presence and Capabilities in IT Security Risk and Compliance Service Offerings Through Acquisition of Control Gap
CyberGuard Advantage acquires Control Gap, enhancing IT security and compliance services. The acquisition strengthens PCI sector capabilities and expands market presence -
PRESS RELEASE
Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
New patent issued for core rare disease target indication for crofelemer by Jaguar Health, enhancing intellectual property protection. Proof-of-concept studies ongoing for SBS and MVID -
-
-
-
-
-
